PE20000120A1 - Composicion de metilfenidato en forma solida para uso topico - Google Patents

Composicion de metilfenidato en forma solida para uso topico

Info

Publication number
PE20000120A1
PE20000120A1 PE1998001219A PE00121998A PE20000120A1 PE 20000120 A1 PE20000120 A1 PE 20000120A1 PE 1998001219 A PE1998001219 A PE 1998001219A PE 00121998 A PE00121998 A PE 00121998A PE 20000120 A1 PE20000120 A1 PE 20000120A1
Authority
PE
Peru
Prior art keywords
methylphenidate
composition
copolymers
presented
refers
Prior art date
Application number
PE1998001219A
Other languages
English (en)
Spanish (es)
Inventor
Juan Mantelle
Terese A Dixon
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26750154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20000120(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of PE20000120A1 publication Critical patent/PE20000120A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
PE1998001219A 1997-12-15 1998-12-15 Composicion de metilfenidato en forma solida para uso topico PE20000120A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6951097P 1997-12-15 1997-12-15
US09/163,351 US6210705B1 (en) 1997-12-15 1998-09-30 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Publications (1)

Publication Number Publication Date
PE20000120A1 true PE20000120A1 (es) 2000-02-19

Family

ID=26750154

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001219A PE20000120A1 (es) 1997-12-15 1998-12-15 Composicion de metilfenidato en forma solida para uso topico

Country Status (28)

Country Link
US (2) US6210705B1 (https=)
EP (2) EP2314288B1 (https=)
JP (3) JP4316800B2 (https=)
KR (1) KR100633348B1 (https=)
CN (1) CN1368876A (https=)
AR (1) AR014062A1 (https=)
AT (1) ATE260652T1 (https=)
AU (1) AU752027B2 (https=)
BR (1) BR9814282A (https=)
CA (1) CA2315237C (https=)
CZ (2) CZ300535B6 (https=)
DE (1) DE69822199T2 (https=)
DK (1) DK1037615T3 (https=)
ES (2) ES2219926T3 (https=)
HK (1) HK1049447A1 (https=)
HU (1) HU226615B1 (https=)
IL (1) IL136760A0 (https=)
LV (1) LV12558B (https=)
NO (1) NO329974B1 (https=)
NZ (1) NZ505689A (https=)
PE (1) PE20000120A1 (https=)
PL (1) PL195315B1 (https=)
PT (1) PT1037615E (https=)
RU (1) RU2233156C2 (https=)
SI (1) SI20360B (https=)
TR (1) TR200001736T2 (https=)
TW (2) TWI242452B (https=)
WO (1) WO1999030694A2 (https=)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US20020102291A1 (en) * 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
GB9913458D0 (en) * 1999-06-09 1999-08-11 Medeva Europ Ltd The therapeutic use of d-threo-methylphenidate
GB9918735D0 (en) * 1999-08-09 1999-10-13 Straken Limited Transdermal patches
CO5261532A1 (es) * 1999-11-15 2003-03-31 Novartis Ag Compuestos heterociclicos sililados, procedimiento para la preparacion de estos y composicion farmaceutica que los contiene
AU2199901A (en) * 1999-12-17 2001-06-25 Medeva Europe Limited The treatment of convulsive states
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE10060550C1 (de) * 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten
ES2559666T3 (es) * 2001-03-07 2016-02-15 Hisamitsu Pharmaceutical Co., Inc. Parche adhesivo
FR2822049B1 (fr) * 2001-03-13 2003-08-01 Dbv Medica 1 Patch destine notamment a depister l'etat de sensibilisation d'un sujet a un allergene, procede de fabrication et utilisation
ES2270746T3 (es) * 2001-03-16 2007-12-01 Alza Corporation Parche transdermico para administrar fentanilo.
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
DE10141652B4 (de) * 2001-08-24 2011-04-07 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung
US20030049272A1 (en) * 2001-08-30 2003-03-13 Yatindra Joshi Pharmaceutical composition which produces irritation
JP4354678B2 (ja) * 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
US6913768B2 (en) 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
CA2542778C (en) * 2003-10-28 2012-05-29 Noven Pharmaceuticals, Inc. Transdermal drug delivery composition
NZ556456A (en) 2005-01-20 2010-12-24 Inst Molecular Medicine Inc Methylphenidate derivatives and uses of them
HRP20110779T1 (hr) * 2005-01-20 2011-12-31 Institute For Molecular Medicine Upotrebe derivata metilfenidata
CA2633599C (en) * 2005-12-23 2015-02-10 Epinamics Gmbh Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
US9393218B2 (en) * 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
CA2643037C (en) * 2006-02-27 2014-08-05 Noven Pharmaceuticals, Inc. Compositions and methods for delivery of amino-functional drugs
AU2007248284B2 (en) * 2006-05-01 2011-03-17 Colgate-Palmolive Company Oral care composition with silicone composite
CA2678806C (en) * 2007-02-21 2017-05-16 Connected Health Systems, Llc Treating adhd and other diseases involving inflammation
MY154027A (en) * 2007-10-15 2015-04-30 Alza Corp Once-a-day replacement transdermal administration of fentanyl
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
FR2924350B1 (fr) * 2007-12-03 2010-08-13 Dbv Tech Procede et compositions pour la vaccination par voie cutanee
EP2219622A1 (en) 2007-12-06 2010-08-25 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
CA2711174A1 (en) * 2007-12-31 2009-07-16 Acclarent, Inc. Mucosal tissue dressing and method of use
FR2926466B1 (fr) * 2008-01-23 2010-11-12 Dbv Tech Procede de fabrication de patchs par electrospray
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
JP5155128B2 (ja) * 2008-12-11 2013-02-27 日東電工株式会社 メチルフェニデート貼付製剤
CA3172541C (en) * 2009-06-05 2026-04-14 Durr Systems, Inc. Improved infrared float bar
EP2364695A1 (en) 2010-02-10 2011-09-14 Nitto Denko Corporation Methylphenidate patch preparation
US20110200663A1 (en) * 2010-02-12 2011-08-18 Nitto Denko Corporation Methylphenidate patch preparation
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
AU2012230733B2 (en) 2011-03-23 2016-10-20 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
CA3123900A1 (en) * 2011-07-28 2013-01-31 Kempharm Inc. Methylphenidate-prodrugs, processes of making and using the same
AR092999A1 (es) 2012-10-15 2015-05-13 Noven Pharma Composiciones y metodos para la administracion transdermica de metilfenidato
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
WO2014106014A1 (en) 2012-12-28 2014-07-03 Noven Pharmaceuticals, Inc Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
AU2013370297A1 (en) 2012-12-28 2015-07-16 Noven Pharmaceuticals, Inc. Multi-polymer compositions for transdermal drug delivery
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US11337936B2 (en) 2013-03-14 2022-05-24 Noven Pharmaceuticals, Inc. Amphetamine transdermal compositions with acrylic block copolymer
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
AR095260A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
CA2932301A1 (en) 2013-12-25 2015-07-02 Fujimoto Co., Ltd. Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
US9980921B2 (en) * 2016-06-30 2018-05-29 Taho Pharmaceuticals Ltd. Transdermal delivery system containing methylphenidate or its salts and methods thereof
SG11201811760VA (en) 2016-07-06 2019-01-30 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
CN106511264A (zh) * 2016-11-15 2017-03-22 北京万全德众医药生物技术有限公司 一种盐酸哌甲酯口服溶液剂及其制备方法
HUE067004T2 (hu) 2016-12-11 2024-10-28 Zevra Therapeutics Inc Metilfenidát prodrogokat tartalmazó készítmények, eljárások azok elõállítására és felhasználására
EP3598982A1 (en) 2018-07-23 2020-01-29 Centre National De La Recherche Scientifique Bioconjugates of neuropeptides derivatives
JP7600661B2 (ja) * 2020-12-11 2024-12-17 ａｒｔｉｅｎｃｅ株式会社 貼付剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4310509A (en) 1979-07-31 1982-01-12 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesive having a broad spectrum antimicrobial therein
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
JP2693212B2 (ja) * 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
AU1992592A (en) * 1991-05-24 1993-01-08 Pharmavene, Inc. Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
US5629019A (en) 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
AU4673993A (en) 1992-07-28 1994-02-14 Procter & Gamble Company, The Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
CH691209A5 (de) 1993-09-06 2001-05-15 Scherrer Inst Paul Herstellungsverfahren für einen Polmerelektrolyten und elektrochemische Zelle mit diesem Polymerelektrolyten.
ES2139778T3 (es) 1994-06-29 2000-02-16 Hennecke Gmbh Procedimiento y dispositivo para la fabricacion continua de bloques o bandas de material de espuma.
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5780050A (en) 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
WO1998039042A1 (en) 1997-03-07 1998-09-11 Jackson Richard R Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
GB9711032D0 (en) 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
US6684641B2 (en) 1999-12-15 2004-02-03 Osaka Gas Co., Ltd. Fluid distributor, burner device, gas turbine engine, and cogeneration system

Also Published As

Publication number Publication date
CN1368876A (zh) 2002-09-11
CZ300535B6 (cs) 2009-06-10
CA2315237A1 (en) 1999-06-24
TR200001736T2 (tr) 2001-01-22
KR100633348B1 (ko) 2006-10-16
AU1824999A (en) 1999-07-05
TWI242452B (en) 2005-11-01
HUP0004539A3 (en) 2006-06-28
CZ2009132A3 (cs) 2016-03-23
EP2314288B1 (en) 2013-12-11
ATE260652T1 (de) 2004-03-15
TWI244396B (en) 2005-12-01
WO1999030694A3 (en) 1999-08-19
NO329974B1 (no) 2011-01-31
SI20360A (sl) 2001-04-30
PL341596A1 (en) 2001-04-23
HU226615B1 (en) 2009-04-28
JP4316800B2 (ja) 2009-08-19
LV12558B (en) 2001-03-20
NO20003096L (no) 2000-08-15
EP2314288A1 (en) 2011-04-27
EP1037615B1 (en) 2004-03-03
PL195315B1 (pl) 2007-08-31
DK1037615T3 (da) 2004-07-12
DE69822199D1 (de) 2004-04-08
KR20010033114A (ko) 2001-04-25
TW200406231A (en) 2004-05-01
JP2013056944A (ja) 2013-03-28
EP1037615A2 (en) 2000-09-27
HUP0004539A2 (hu) 2001-06-28
HK1049447A1 (zh) 2003-05-16
JP2009073856A (ja) 2009-04-09
SI20360B (sl) 2008-06-30
BR9814282A (pt) 2000-10-03
HK1156872A1 (en) 2012-06-22
WO1999030694A2 (en) 1999-06-24
RU2233156C2 (ru) 2004-07-27
CA2315237C (en) 2009-12-01
JP2002510600A (ja) 2002-04-09
NO20003096D0 (no) 2000-06-15
US6210705B1 (en) 2001-04-03
DE69822199T2 (de) 2005-02-17
NZ505689A (en) 2003-01-31
AU752027B2 (en) 2002-09-05
IL136760A0 (en) 2001-06-14
CZ20002209A3 (cs) 2000-11-15
PT1037615E (pt) 2004-07-30
ES2219926T3 (es) 2004-12-01
CZ305817B6 (cs) 2016-03-23
LV12558A (lv) 2000-11-20
ES2452517T3 (es) 2014-04-01
US6348211B1 (en) 2002-02-19
AR014062A1 (es) 2001-01-31

Similar Documents

Publication Publication Date Title
PE20000120A1 (es) Composicion de metilfenidato en forma solida para uso topico
CA2044132A1 (en) Transdermal Acrylic Multipolymer Drug Delivery System
DE69535328D1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
FI904358A0 (fi) Transdermalt multipolymert administrationssystem foer laekemedel.
PE88699A1 (es) Formas de dosificacion de liberacion sostenida de sertralina
ES2084390T3 (es) Comprimidos de liberacion controlada, de varias capas, que contienen tanto naproxen como sal sodica de naproxen.
MY105347A (en) Transdermal therapeutic system comprising as active component buprenorphine
ES2086617T3 (es) Composicion cosmetica dermatologica a base de mezclas polivitaminicas.
ES2042146T3 (es) Barra adhesiva con fuerza de pegado mejorada.
AU5881794A (en) Transdermal therapeutic system with galanthamine as active ingredient
AR055552A1 (es) Preparacion topica refrescante para parches y metodos para utilizar la misma
BR9403783A (pt) Uso de uma composição cosmética
NO923699D0 (no) Fremgangsmaate og innretning for medisering via hud
DE59900497D1 (de) Transdermales therapeutisches system (tts) oxybutynin enthaltend
ATE237331T1 (de) Deuterierte wirkstoffe in transdermaler applikation
ATE300606T1 (de) Waschmittelformkörper mit verbesserten auflöseeigenschaften
ES2062022T3 (es) Composicion adhesiva antibacteriana.
YU48663B (sh) Flaster koji sadrži nitroglicerin i postupak za njegovo dobijanje
UA83036C2 (ru) Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ
ES2193523T3 (es) Composiciones depilatorias, su preparacion y uso.
ATE185069T1 (de) Flächenstabilisierte pharmazeutische zubereitung zur anwendung auf der haut
TR199800008T1 (xx) Ametokain ihtiva eden suyla aktive edilebilir yap��kan matrisi.
SG160201A1 (en) Electroprocessing in drug delivery and cell encapsulation
ES2063455T3 (es) Nueva forma unitaria, solida y porosa que comprende particulas en forma de perlas asi como su preparacion.
NZ509029A (en) Sticking plaster for controlled release of natural interferon for transcutaneous absorption

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed